
Greenlight Biosciences, an RNA Firm is Going Public in a $1.5 Billion Deal
Greenlight Biosciences, an RNA tech firm is driving towards improving the availability of mRNA vaccines. The company has also been producing RNA-based pesticides as an alternative. The company wants to be capable of mass production of mRNA vaccines, as well as substances based on RNA that can be used to